FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 114 filers reported holding FIVE PRIME THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 1.98 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $3,390,000 | +3625.3% | 90,000 | +365.3% | 0.01% | – |
Q3 2020 | $91,000 | -22.9% | 19,344 | 0.0% | 0.00% | -100.0% |
Q2 2020 | $118,000 | +24.2% | 19,344 | -6.9% | 0.00% | – |
Q4 2019 | $95,000 | +458.8% | 20,779 | +372.2% | 0.00% | – |
Q3 2019 | $17,000 | -81.1% | 4,400 | -34.1% | 0.00% | – |
Q1 2019 | $90,000 | +7.1% | 6,680 | +187.7% | 0.00% | – |
Q1 2017 | $84,000 | -84.4% | 2,322 | -79.7% | 0.00% | -100.0% |
Q4 2016 | $540,000 | +27.1% | 11,441 | +41.4% | 0.00% | 0.0% |
Q3 2016 | $425,000 | +543.9% | 8,092 | +406.4% | 0.00% | – |
Q2 2016 | $66,000 | – | 1,598 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 115,500 | $2,531,000 | 0.89% |
AWM Investment Company, Inc. | 150,000 | $3,288,000 | 0.64% |
BB BIOTECH AG | 827,500 | $18,139,000 | 0.51% |
Virtus ETF Advisers LLC | 17,371 | $381,000 | 0.48% |
Rock Springs Capital Management LP | 425,000 | $9,316,000 | 0.42% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 450,728 | $9,880,000 | 0.39% |
Telemetry Investments, L.L.C. | 44,176 | $968,000 | 0.37% |
RTW INVESTMENTS, LP | 100,377 | $2,200,000 | 0.37% |
Eventide Asset Management | 315,000 | $6,905,000 | 0.36% |
ACUTA CAPITAL PARTNERS, LLC | 52,500 | $1,151,000 | 0.22% |